PICC's Resilience, Angelalign's Surge, and the Rest of the Hong Kong Shuffle

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Taking a look across the Hong Kong market right now, we are seeing a fascinating split screen—from steady financial juggernauts to companies trying to orchestrate massive turnarounds.

Let's start with the big one: PICC (1339.HK). The financial powerhouse has shown real resilience. With property and casualty premiums growing steadily to RMB 538.1 billion in their recent full-year numbers, the auto insurance business continues to serve as a reliable ballast. Heading deeper into 2026, their life and health segments are also chipping in with solid single-digit growth.

Over in the medical tech space, Angelalign (6960.HK) has been on a tear. The clear aligner maker has seen its stock rally significantly in recent months, fueled by strong H1 2026 earnings and a massive bump in global case volumes. On the flip side, real estate developer China SCE Group Holdings (380.HK) is still grinding through its turnaround. In August 2026, a Hong Kong court finally greenlit its USD 2.27 billion offshore debt restructuring plan—giving the company some much-needed breathing room to pivot back to asset-light operations.

Here is what else is going on:

  • Xinte Energy (830.HK): The polysilicon titan is locking down massive deals, recently signing a strategic agreement to supply 150,000 tons to Shuangliang in a bid to secure long-term revenue.
  • Yonghe Medical (6700.HK): The hair transplant chain is crushing it. Net profit skyrocketed 170.9% in H1 2026, and founder Zhang Yu is now aggressively pushing clinical expansions into Turkey and Southeast Asia.
  • Swire Pacific (422.HK): Swire Pacific's aviation arm is seeing some serious movement, buoyed by its associate Cathay Pacific's pledge to inject over HKD 100 billion into maintaining Hong Kong's hub status.
  • Bodibra (8297.HK): The underwear manufacturer just announced a share placement to shore up its working capital. Despite a recent dip in net sales, the company managed to post improved net profit margins in its 2026 report.
  • China ITS (8037.HK) and China Communications Construction (6055.HK): Both infrastructure players continue to quietly execute on their rail and energy projects. No massive headlines recently, but they remain steady operators in their sectors.
  • CSOP Hang Seng Index ETF (2818.HK): As the classic vehicle for tracking the broader Hang Seng, it remains the ultimate barometer for the macro environment surrounding these specific names.

Source: Global Report The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.